Myelomeningocele in young adults.
Christopher R J Woodhouse
https://pubmed.ncbi.nlm.nih.gov/15667645/Actively Recruiting
Led by University of Wisconsin, Madison · Updated on 2024-04-03
100
Participants Needed
1
Research Sites
N/A
Total Duration
Children born with congenital urinary tract anomalies are at high risk for kidney infections and scarring, which may lead to kidney problems in adulthood. This research aims to evaluate a new rapid imaging method called quick renal MRI as a radiation-free, injection-free, and sedation-free alternative to the current standard 99mTechnetium-dimercaptosuccinic acid 99mTc-DMSA renal scan. The study compares the quick renal MRIs accuracy to the DMSA scan in detecting acute kidney infections and scars, with results potentially easing testing burdens for children with chronic kidney disease. The study has two parts Aim 1 involves inpatients with acute or suspected kidney infections who will have both a clinical DMSA scan and a quick MRI within one week, preferably during their hospital stay. Aim 2 includes patients visiting clinics for kidney scarring evaluations, who will have both scans scheduled within six months. All participants undergo both the DMSA and quick MRI scans to assess the quick MRIs validity. Participants aged from newborn to 21 years will be involved for durations ranging from one week Aim 1 to six months Aim 2. During the quick MRI, which takes about 15 minutes without injections or sedation, participants lie still while wearing protective headphones. Parents can stay with young children in the scanner for comfort. Researchers will measure how well the quick MRI detects infections and scarring compared to the DMSA scan. This includes sensitivity and specificity assessments, with the study concluding by early 2025.
CONDITIONS
The Validity of the Quick Renal MRI in Pediatric Kidney Disease
S
Shannon Cannon, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Wisconsin, Madison
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Quick MRI (15-minute rapid MRI scan without sedation) | DMSA scan (dimercaptosuccinic acid renal scintigraphy) |
|---|---|---|
| What it is | A rapid magnetic resonance imaging protocol designed for children, performed without sedation or intravenous contrast, aiming to visualize kidney inflammation or scarring in under 15 minutes. | A nuclear medicine test using dimercaptosuccinic acid tracer to identify areas of kidney injury or scarring, considered the established reference standard for pediatric acute pyelonephritis and renal scars. |
| Role in the trial | Quick MRI is the investigational diagnostic approach being tested for its sensitivity and specificity compared to DMSA scans in the same participants. | DMSA scan serves as the clinical reference standard and comparator for Quick MRI results within the trial. |
| Primary use | Intended to diagnose acute kidney infections and detect areas of renal scarring in children, potentially offering a faster and less invasive alternative to nuclear imaging. | Established method for detecting infection-related and chronic kidney scars, routinely used in pediatric practice to confirm acute pyelonephritis and renal damage. |
| How it is given or performed | Children lie flat for a 15-minute MRI; no sedation or IV required. Parents may accompany their child. Protective headphones are provided. | Children receive an intravenous injection of a radioactive tracer. Images are obtained over several hours to highlight areas of kidney injury or scarring. |
| Evidence status | Diagnostic performance and clinical utility for pyelonephritis and renal scarring are still under investigation; trial results not yet posted. | Long-established evidence supports DMSA scintigraphy as highly sensitive and specific for acute infection and renal scarring in children. |
| Important risks | MRI is non-invasive and does not use ionizing radiation or IV contrast, but may be uncomfortable for children who struggle to remain still or tolerate loud scanner noises. | DMSA scan exposes children to low levels of radiation and requires intravenous injection; rare allergic reactions to the tracer may occur. |
| Important limitations | Diagnostic accuracy of Quick MRI is not yet fully established for kidney scarring and infection. Children must lie still in the scanner, and the technique may miss small or subtle lesions. Fast protocols can reduce resolution compared to standard MRI. | DMSA scan involves radiation exposure, takes several hours, and requires intravenous tracer injection. The nuclear imaging process may not be readily available in some centers and can be distressing for young children. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 1 week for acute infection cases; up to 6 months for renal scarring cases
Participants undergo both the standard DMSA renal scan and the quick renal MRI to detect acute renal infections or renal scars. These imaging tests are scheduled within a short timeframe of each other depending on the participant's clinical status.
1 to 2 visits depending on clinical indication and timing of scans
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Christopher R J Woodhouse
https://pubmed.ncbi.nlm.nih.gov/15667645/A Hoberman, H P Chao, D M Keller...
https://pubmed.ncbi.nlm.nih.gov/8320616/Pierre-Hugues Vivier, Asmaa Sallem, Marion Beurdeley...
https://pubmed.ncbi.nlm.nih.gov/23884301/Jonathan C Routh, Earl Y Cheng, J Christopher Austin...
https://pubmed.ncbi.nlm.nih.gov/27475969/Bermans J Iskandar, Jason M Sansone, Joshua Medow...
https://pubmed.ncbi.nlm.nih.gov/15835101/Hsin-Hsiao S Wang, Jessica C Lloyd, John S Wiener...
https://pubmed.ncbi.nlm.nih.gov/26926542/Arzu Kovanlikaya, Nese Okkay, Handan Cakmakci...
https://pubmed.ncbi.nlm.nih.gov/14975495/H G Rushton, M Majd
https://pubmed.ncbi.nlm.nih.gov/1331545/J R MacKenzie
https://pubmed.ncbi.nlm.nih.gov/8692483/Alison Christy, Charles Murchison, Jenny L Wilson
https://pubmed.ncbi.nlm.nih.gov/29174005/University of Wisconsin, Madison
Lead Sponsor